C. Halldin

Medicine · Health Sciences

12h-index1.3kcitations59works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Medical Imaging Techniques and Applications(20), Radiopharmaceutical Chemistry and Applications(8), Neuroscience and Neuropharmacology Research(7), Schizophrenia research and treatment(6), Neurotransmitter Receptor Influence on Behavior(6)

Publications59 total

Development of novel C-11- labeled ASEM analogs for detection of neuronal nicotinic acetylcholine receptors (alpha 7-nAChR)
European Journal of Nuclear Medicine and Molecular Imaging·2019
Social cognition in autism spectrum disorder is associated with brain serotonin transporter availability
European Neuropsychopharmacology·2017
A multicenter positron emission tomography study of GABA receptor availability in adults with autism
European Neuropsychopharmacology·2017
P.1.i.028 Brain phosphodiesterase 10A occupancy measured by PET after oral administration of TAK-063, a newly developed phosphodiesterase 10A inhibitor, in human volunteers
European Neuropsychopharmacology·2015
P.1.g.069 Relationship between dose, plasma concentration and GABA-A receptor occupancy by partial GABA-A receptor modulators
European Neuropsychopharmacology·2015
P.1.i.025 Brain PET measurement of phosphodiesterase 10A occupancy by TAK-063, a new phosphodiesterase 10A inhibitor, using [11C]T-773 in nonhuman primates
European Neuropsychopharmacology·2015
Safety and efficacy of recombinant human platelet derived growth factor (Rhpdgf) in Parkinson's disease
Journal of the Neurological Sciences·2013· 2 cited
New PET radiopharmaceuticals beyond FDG for brain tumor imaging.
PubMed·2012· 103 cited
P.3.004 Amphetamine-opioid interactions in the human brain reward system – a PET study using [11C]carfentanil
European Neuropsychopharmacology·2012
P.1.e.030 In vivo monoamine transporter occupancy by venlafaxine and milnacipran in non-human primates
European Neuropsychopharmacology·2011
P.1.e.021 In vivo assessment of changes in serotonin release in the non-human primate brain using PET and [11C]AZ10419369
European Neuropsychopharmacology·2010
P.3.009 Effects of naltrexone on amphetamine-induced changes in the brain dopamine system
European Neuropsychopharmacology·2010
Brain tumor imaging: EANM procedure guidelines
Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B))·2010
Brain tumour imaging
Lirias (KU Leuven)·2010
P.1.e.019 PET-measured occupancy of the norepinephrene transporter by extended release quetiapine fumarate (quetiapine XR) in brains of healthy subjects
European Neuropsychopharmacology·2008· 12 cited
P.3.24 Lower 5-HT1A receptor binding in patients with borderline personality disorder: a PET study using [11C]WAY100635
European Neuropsychopharmacology·2008
P.3.02 Molecular imaging of the 5-HT1A receptor and 5-HTT in relation to cognitive functions in man
European Neuropsychopharmacology·2008
Radiosynthesis of [11C]MNPA from the precursor (R)-(−)-2-hydroxy-10,11-acetonide-NPA and a preliminary test–retest PET analysis in monkey brain
NeuroImage·2008· 1 cited
S.07.04 Gender differences in the 5-HT1A receptor and serotonin transporter in the human brain: a PET study
European Neuropsychopharmacology·2007
P.1.e.016 No changes in 5-HT1A receptor and serotonin transporter between phases of the menstrual cycle in healthy women
European Neuropsychopharmacology·2007
page 1 of 3Next →

Frequent Co-authors

Lars Farde(21), Per Karlsson(7), Sigrid Nyberg(6), S. Asenbaum(6), G. Sedvall(5), Klaus Tatsch(5), Sharon Stone‐Elander(5), Anna Nordström(4), Håkan Hall(4), L. Widén(4), Andrea Varrone(4), Johan Lundberg(4), Balázs Gulyás(3), A. Catafau(3), Alberto Pupi(3), Peter Bartenstein(3), Akihiro Takano(3), Aurelija Jučaitė(3), Swahn Cg(3), G. Blomqvist(3)